Tetradecanoylphorbol-13-acetate (TPA) significantly increases AAV2/5 transduction of human neuronal cells in vitro

Tetradecanoylphorbol-13-acetate (TPA) significantly increases AAV2/5 transduction of human neuronal cells in vitro

Show other versions (1)

Recombinant adeno-associated virus type 2 (AAV2) vectors have shown great promise in current ophthalmology clinical trials targeting gene delivery to the retinal pigment epithelium (RPE). To treat the majority of retinal diseases, however, gene delivery would need to be targeted to photoreceptor neu...

Full description

Bibliographic Details
Main Authors:	You, Q, Brown, L, McClements, M, Hankins, M, MacLaren, R
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Tetradecanoylphorbol-13-acetate (TPA) significantly increases AAV2/5 transduction of human neuronal cells in vitro.
by: You, Q, et al.
Published: (2012)

Stimulation of melanogenesis by tetradecanoylphorbol 13-acetate (TPA) in mouse melanocytes and neural crest cells.
by: Prince, S, et al.
Published: (2003)

Suppression of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation in mice by transduced Tat-Annexin protein
by: Sun Hwa Lee1,#, Dae Won Kim1,#, Seon Ae Eom1, Se-Young Jun1, Meeyoung Park1, Duk-Soo Kim2, Hyung Joo Kwon3, Hyeok Yil Kwon4, Kyu Hyung Han1, Jinseu Park1, Hyun Sook Hwang1, Won Sik Eum1,* & Soo Young Choi1,*
Published: (2012-06-01)

Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina
by: Patrício, M, et al.
Published: (2017)

Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes
by: McClements, M, et al.
Published: (2017)

Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina
by: Maria I. Patrício, et al.
Published: (2017-03-01)

Accurate Quantification of AAV Vector Genomes by Quantitative PCR
by: Cristina Martinez-Fernandez de la Camara, et al.
Published: (2021-04-01)

Cell-mediated inflammatory response to AAV gene therapy in the retina
by: Chandler, LC, et al.
Published: (2020)

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
by: Han, RC, et al.
Published: (2021)

Promoter orientation within an AAV-CRISPR vector affects Cas9 expression and gene editing efficiency
by: Fry, LE, et al.
Published: (2020)

RNA editing for Usher syndrome using CRISPR-Cas13
by: Fry, LE, et al.
Published: (2020)

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
by: Chandler, LC, et al.
Published: (2021)

Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4-/- mouse and bipolar cells in the rd1 mouse and human retina ex-vivo
by: De Silva, S, et al.
Published: (2016)

Impact of vital dyes on cell viability and transduction efficiency of AAV vectors used in retinal gene therapy surgery: an in vitro and in vivo analysis
by: Salvetti, A, et al.
Published: (2017)

Gene therapy for retinal disease.
by: McClements, M, et al.
Published: (2013)

Anti-inflammatory activity of Haruan (Channa striatus bloch) cream on 12-O-tetradecanoylphorbol-13-acetate-induced chronic dermatitis in mice model
by: Mohamad Isa, Irma Izani
Published: (2015)

12-<i>O</i>-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP
by: Chang Wan Kim, et al.
Published: (2022-12-01)

An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction
by: Miguel C. Santoscoy, et al.
Published: (2023-06-01)

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
by: Laurel C. Chandler, et al.
Published: (2021-09-01)

Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines.
by: Ammar Abou-Kandil, et al.
Published: (2012-01-01)

Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina
by: Hickey, DG, et al.
Published: (2017)

Choroideremia: molecular mechanisms and development of AAV gene therapy
by: Patrício, M, et al.
Published: (2018)

Glycogen Synthase Kinase-3β Facilitates Cytokine Production in 12-O-Tetradecanoylphorbol-13-Acetate/Ionomycin-Activated Human CD4<sup>+</sup> T Lymphocytes
by: Cheng-Chieh Tsai, et al.
Published: (2020-06-01)

Kaempferol Blocks the Skin Fibroblastic Interleukin 1β Expression and Cytotoxicity Induced by 12-O-tetradecanoylphorbol-13-acetate by Suppressing c-Jun N-terminal Kinase
by: Su-Ji Park, et al.
Published: (2021-09-01)

Suppression of Urokinase-Type Plasminogen Activator Receptor by Docosahexaenoic Acid Mediated by Heme Oxygenase-1 in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Human Endothelial Cells
by: Sen Lian, et al.
Published: (2020-11-01)

Insights on the regeneration potential of Müller glia in the mammalian retina
by: Salman, A, et al.
Published: (2021)

The Scope of Pathogenic ABCA4 Mutations Targetable by CRISPR DNA Base Editing Systems—A Systematic Review
by: Elena Piotter, et al.
Published: (2022-01-01)

Preferential transduction of parvalbumin-expressing cortical neurons by AAV-mDLX5/6 vectors
by: Padideh Yazdan-Shahmorad, et al.
Published: (2024-02-01)

AAV11 enables efficient retrograde targeting of projection neurons and enhances astrocyte-directed transduction
by: Zengpeng Han, et al.
Published: (2023-06-01)

An AAV dual vector strategy ameliorates the Stargardt phenotype in adult Abca4−/− mice
by: McClements, ME, et al.
Published: (2018)

Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
by: Alejandro Orlowski, et al.
Published: (2020-03-01)

A custom-made AAV1 variant (AAV1-T593K) enables efficient transduction of Japanese quail neurons in vitro and in vivo
by: Shaden Zoabi, et al.
Published: (2023-03-01)

Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa
by: Fischer, MD, et al.
Published: (2017)

Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
by: Dzerassa Gurtsieva, et al.
Published: (2024-01-01)

Better Targeting, Better Efficiency for Wide-scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B
by: Kasey L Jackson, et al.
Published: (2016-11-01)

CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues
by: Ahmed Salman, et al.
Published: (2024-01-01)

CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in <i>Rhodopsin</i>
by: Maria Kaukonen, et al.
Published: (2022-07-01)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
by: Ariel Kantor, et al.
Published: (2020-08-01)

A Review of CRISPR Tools for Treating Usher Syndrome: Applicability, Safety, Efficiency, and In Vivo Delivery
by: Lauren Major, et al.
Published: (2023-04-01)

Therapy Approaches for Stargardt Disease
by: Elena Piotter, et al.
Published: (2021-08-01)